DD Notes ~ http://www.ddnotesmaker.com/MCET
##### recent news/filings ~ source: finance.yahoo.com
Fri, 28 Feb 2014 20:36:21 GMT ~ MULTICELL TECHNOLOGIES, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and
read full: http://biz.yahoo.com/e/140228/mcet8-k.html
*********************************************************
Fri, 28 Feb 2014 14:45:46 GMT ~ MULTICELL TECHNOLOGIES, INC. Files SEC form 10-K, Annual Report
read full: http://biz.yahoo.com/e/140228/mcet10-k.html
*********************************************************
Wed, 15 Jan 2014 13:39:00 GMT ~ MultiCell Technologies Files Patent Application Covering New Class of RNA Therapeutics
- WOONSOCKET, R.I., Jan. 15, 2014 /PRNewswire/ -- MultiCell Technologies, Inc. (OTC Bulletin Board: MCET.OB) has filed a U.S. provisional patent application concerning composition of matter, biological targets, mechanism of action, methods and formulations to achieve targeted tumor cell death. This patent application describes a novel class of very small noncoding double stranded RNA molecules (VSRNAs) which interfere with the basic homeostatic cellular processes in tumor cells. VSRNAs are of molecular size less than 10 bps, yet are surprisingly capable in their ability to affect the metabolism, viability and proliferative rate of tumor cells consistent with a mechanism of action that bypasses completely, or in part, the canonical known pathways and steps of RNA recognition and RNA interference.
read full: http://finance.yahoo.com/news/multicell-techn...00771.html
*********************************************************
Thu, 21 Nov 2013 14:22:51 GMT ~ MULTICELL TECHNOLOGIES, INC. Files SEC form 8-K, Submission of Matters to a Vote of Security Holders
read full: http://biz.yahoo.com/e/131121/mcet8-k.html
*********************************************************
Wed, 13 Nov 2013 13:13:00 GMT ~ MultiCell Technologies Files U.S. Patent Application for Targeted Delivery of MCT-485, a Noncoding miRNA for Cancer Treatment
- WOONSOCKET, R.I., Nov. 13, 2013 /PRNewswire/ -- MultiCell Technologies, Inc. (OTC Bulletin Board: MCET.OB) has filed a second U.S. patent application concerning methods and formulations to achieve targeted tumor cell death. MCT-485 is a noncoding double stranded micro RNA (miRNA) which has demonstrated oncolytic and immune stimulating activity in in vitro models of hepatocellular carcinoma. MCT-485 is currently being evaluated in animal models of hepatocellular carcinoma. This invention addresses the need to direct the powerful biological effect of miRNAs such as MCT-485 towards tumor cells and away from normal tissues. This patent application describes compositions and methods that target populations of cancerous cells which have an enhanced capability to mediate the process of relapse, progression and metastasis. Not all cancer cells have a tumor initiating capability; this U.S. patent application describes compositions and methods that target cancer by delivering a biologically active, cytotoxic payload of miRNA to only those cells having the highest tumor initiating capability that are part of the cancerous process such as cancer stem cells and tumor initiating cells, and to kill those cells without killing cells not directly involved in the process of relapse, progression and metastasis of cancer.
read full: http://finance.yahoo.com/news/multicell-techn...00785.html
*********************************************************
##### chart ~ source: stockcharts.com
stockcharts.com/c-sc/sc?s=MCET&p=D&b=5&g=0&id=p95448242713
##### chart ~ source: eoddata.com
http://chart.eoddata.com/?e=OTCBB&s=MCET&...D&b=BB
##### company info ~ source: otcmarkets.com
Link: http://www.otcmarkets.com/stock/MCET/company-info
Ticker: $MCET
OTC Market Place: OTCQB
CIK code: 0000811779
Company name: MultiCell Technologies, Inc.
Company website: http://www.multicelltech.com
Incorporated In: DE, USA
##### extra dd links
Edgar filings: http://www.sec.gov/cgi-bin/browse-edgar?actio...p;count=40
Latest filings: http://www.otcmarkets.com/stock/MCET/filings
Latest financials: http://www.otcmarkets.com/stock/MCET/financials
Latest news: http://www.otcmarkets.com/stock/MCET/news - http://finance.yahoo.com/q/h?s=MCET+Headlines
Major holdings: http://data.cnbc.com/quotes/MCET/tab/8.1
Insider transactions (1): http://finance.yahoo.com/q/it?s=MCET+Insider+Transactions
Insider transactions (2): http://www.secform4.com/insider-trading/MCET.htm
Insider transactions (3): http://www.insidercow.com/history/company.jsp?company=MCET
RegSho: http://www.regsho.com/tools/symbol_stats.php?...rch=search
DTCC: http://search2.dtcc.com/?q=MultiCell+Technolo...ISO-8859-1
Spoke company information: http://www.spoke.com/search?utf8=%E2%9C%93&am...ies%2C+Inc.
Corporation WIKI: http://www.corporationwiki.com/search/results...=0&y=0
WHOIS: http://whois.domaintools.com/http://www.multicelltech.com
Alexa: http://www.alexa.com/siteinfo/http://www.multicelltech.com#
Corporate website internet archive: http://web.archive.org/web/*/http://www.multicelltech.com
http://www.pennystocktweets.com/stocks/profile/MCET
##### last known share structure ~ source: otcmarkets.com
Market Value: $2,010,769 a/o Feb 28, 2014
Shares Outstanding: 2,513,461,835 a/o Oct 08, 2013
Float: 600,000 a/o Mar 30, 2004
Authorized Shares: 3,000,000,000 a/o Jul 01, 2013
Par Value: 0.01
##### business description ~ source: otcmarkets.com
IC
DD Notes ~ http://www.ddnotesmaker.com/MCET